What is MedaCheck?
MedaCheck, LLC operates at the intersection of clinical efficiency and secure data architecture. Its flagship platform, Titan, provides a robust, HIPAA-compliant environment tailored for healthcare organizations, medical device manufacturers, and research entities. By integrating advanced API capabilities with specialized medical adherence tools, the company addresses critical gaps in patient health management. The platform is engineered to support high-stakes environments, including clinical trials and large-scale medical software deployments, positioning MedaCheck as a vital utility provider within the broader Health IT ecosystem.
How much funding has MedaCheck raised?
MedaCheck has raised a total of $1.2M across 2 funding rounds:
Series A
$1.1M
Debt
$11K
Series A (2015): $1.2M with participation from Queen City Angels
Debt (2021): $11K led by PPP
Key Investors in MedaCheck
Queen City Angels
An investor network focused on supporting entrepreneurs and early-stage companies through capital, mentorship, and strategic guidance.
PPP
Public-Private Partnership
What's next for MedaCheck?
With this recent injection of growth capital, MedaCheck is well-positioned to accelerate its product roadmap and expand its footprint in the clinical research and medical device sectors. The company's focus remains on enhancing the interoperability of the Titan platform, ensuring that its secure data storage and adherence functionalities meet the evolving regulatory and operational demands of its enterprise clients. As the digital health landscape continues to consolidate, MedaCheck's ability to provide a reliable, compliant, and scalable backend will be a key driver of its long-term market penetration and competitive differentiation.
See full MedaCheck company page
